Assyro AI

FDA Orange Book · active-ingredient family

Flecainide acetate

Flecainide acetate is approved as 1 brand and 10 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:TAMBOCOR · NDA 018830

1

Brand (NDA)

10

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
TAMBOCORRLD×4ALVOGENNDA 018830Aug 23, 1988

Generic (ANDA) products (10)

ProductApplicantApplicationTEApproved
FLECAINIDE ACETATE×3OMSAV PHARMAANDA 218093ABApr 22, 2026
FLECAINIDE ACETATE×3YICHANG HUMANWELLANDA 215599ABSep 08, 2022
FLECAINIDE ACETATE×3REGCON HOLDINGSANDA 210683ABSep 16, 2020
FLECAINIDE ACETATE×3AUROBINDO PHARMA LTDANDA 202821ABNov 03, 2017
FLECAINIDE ACETATE×3CHARTWELLANDA 079164Jul 09, 2009
FLECAINIDE ACETATE×3SUN PHARM INDS LTDANDA 076421ABMar 28, 2003
FLECAINIDE ACETATE×3HIKMAANDA 076278ABJan 14, 2003
FLECAINIDE ACETATE×3ANI PHARMSANDA 075882ABOct 28, 2002
FLECAINIDE ACETATE×3ANI PHARMSANDA 076030Oct 28, 2002
FLECAINIDE ACETATE×3AMNEAL PHARMANDA 075442ABJul 31, 2001

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Flecainide acetate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.